Understand the source comparison
Best Peptides for Low Sex Drive Women: Mechanism Comparison
PT-141 (Bremelanotide) Melanocortin-4 receptor agonist. Activates hypothalamic desire circuits independent of hormone levels 30–45 minutes subcutaneous FDA-approved for HSDD based on Phase 3 RCTs (n=1,267). Strongest human evidence Subcutaneous injection Most
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- PT-141 (Bremelanotide)
- Melanocortin-4 receptor agonist. Activates hypothalamic desire circuits independent of hormone levels
- 30–45 minutes subcutaneous
- FDA-approved for HSDD based on Phase 3 RCTs (n=1,267). Strongest human evidence
- Subcutaneous injection
- Most robust clinical data for on-demand sexual desire enhancement in premenopausal women
- Kisspeptin-10
- GnRH neuron activation. Restores HPG axis pulsatility and enhances limbic response to sexual cues
- 60–90 minutes intravenous
- Controlled trials show limbic activation and subjective desire improvement. Investigational only
- Intravenous or subcutaneous
- Best suited for HSSD linked to hypothalamic suppression (FHA, PCOS, chronic stress)
- Oxytocin
- Pair-bonding neuropeptide. Reduces amygdala threat reactivity, enhances trust and genital sensitivity
- 20–30 minutes intranasal
- Moderate evidence from small RCTs. Effects strongest in anxiety-related sexual dysfunction
- Intranasal spray
- Most effective for emotional/trauma-related arousal barriers rather than primary desire deficits